Generic versions of Mirapex (pramipexole) are available at this time. Generic Mirapex comes in six strengths and is made by various manufacturers, including Sandoz and Teva Pharmaceuticals USA.
Generic Mirapex: An OverviewMirapex® (pramipexole dihydrochloride) is a prescription medication. It is part of a group of medications known as dopamine agonists and is approved to treat restless legs syndrome (RLS) and Parkinson's disease.
Mirapex is made by Boehringer Ingelheim Pharmaceuticals, Inc. However, a generic version of Mirapex is also available. Although the first patent did not expire until March 2011, a lawsuit settlement allowed Barr Pharmaceuticals, which has been sold to Teva Pharmaceuticals USA, to make a generic version earlier. Several manufacturers now make generic Mirapex.
Strengths of Generic MirapexGeneric Mirapex tablets are available in the following strengths:
- Pramipexole dihydrochloride 0.125 mg
- Pramipexole dihydrochloride 0.25 mg
- Pramipexole dihydrochloride 0.5 mg
- Pramipexole dihydrochloride 0.75 mg
- Pramipexole dihydrochloride 1 mg
- Pramipexole dihydrochloride 1.5 mg.
Who Makes Generic Mirapex?
Generic Mirapex is made by various manufacturers, such as:
- Teva Pharmaceuticals USA
- Zydus Pharmaceuticals USA, Inc.
Is Generic Pramipexole as Good as Mirapex?
All generic medications must undergo certain tests to compare them to brand-name medications. The U.S. Food and Drug Administration (FDA) then looks at these tests to decide if the generics are equivalent to the brand-name medications and assigns a rating to each one.
An "AB" rating means that the FDA has determined that a generic medication is equivalent to a brand-name medication. All of the generic pramipexole versions currently available have an "AB" rating, meaning they should be equivalent to Mirapex.
However, generic medications are allowed to have different inactive ingredients than the brand-name medication. This might include fillers, dyes, or other ingredients that may cause problems for people with allergies or sensitivities.